Works by Gómez-Cañas, Maria

Results: 14

Δ9 -Tetrahydrocannabinolic acid alleviates collagen-induced arthritis: Role of PPARγ and CB1 receptors.
Published in:
2020
By:
- Palomares, Belén;
- Garrido‐Rodriguez, Martín;
- Gonzalo‐Consuegra, Claudia;
- Gómez‐Cañas, María;
- Saen‐oon, Suwipa;
- Soliva, Robert;
- Collado, Juan A.;
- Fernández‐Ruiz, Javier;
- Morello, Gaetano;
- Calzado, Marco A.;
- Appendino, Giovanni;
- Muñoz, Eduardo;
- Garrido-Rodriguez, Martín;
- Gonzalo-Consuegra, Claudia;
- Gómez-Cañas, María;
- Saen-Oon, Suwipa;
- Fernández-Ruiz, Javier
Publication type:
journal article
VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARγ- and CB2 receptor-dependent pathways.
Published in:
2018
By:
- del Rio, Carmen;
- Cantarero, Irene;
- Palomares, Belén;
- Gómez‐Cañas, María;
- Fernández‐Ruiz, Javier;
- Pavicic, Carolina;
- García‐Martín, Adela;
- Luz Bellido, Maria;
- Ortega‐Castro, Rafaela;
- Pérez‐Sánchez, Carlos;
- López‐Pedrera, Chary;
- Appendino, Giovanni;
- Calzado, Marco A.;
- Muñoz, Eduardo;
- Gómez-Cañas, María;
- Fernández-Ruiz, Javier;
- García-Martín, Adela;
- Ortega-Castro, Rafaela;
- Pérez-Sánchez, Carlos;
- López-Pedrera, Chary
Publication type:
journal article
Prospects for cannabinoid therapies in basal ganglia disorders.
Published in:
2011
By:
- Fernández-Ruiz, Javier;
- Moreno-Martet, Miguel;
- Rodríguez-Cueto, Carmen;
- Palomo-Garo, Cristina;
- Gómez-Cañas, María;
- Valdeolivas, Sara;
- Guaza, Carmen;
- Romero, Julián;
- Guzmán, Manuel;
- Mechoulam, Raphael;
- Ramos, José A;
- Fernández-Ruiz, Javier;
- Rodríguez-Cueto, Carmen;
- Gómez-Cañas, María;
- Romero, Julián;
- Guzmán, Manuel;
- Ramos, José A
Publication type:
journal article
Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor.
Published in:
2018
By:
- García, Concepción;
- Gómez-Cañas, María;
- Burgaz, Sonia;
- Palomares, Belén;
- Gómez-Gálvez, Yolanda;
- Palomo-Garo, Cristina;
- Campo, Sara;
- Ferrer-Hernández, Joel;
- Pavicic, Carolina;
- Navarrete, Carmen;
- Luz Bellido, M.;
- García-Arencibia, Moisés;
- Ruth Pazos, M.;
- Muñoz, Eduardo;
- Fernández-Ruiz, Javier
Publication type:
journal article
Description of a Bivalent Cannabinoid Ligand with Hypophagic Properties.
Published in:
Archiv der Pharmazie, 2013, v. 346, n. 3, p. 171, doi. 10.1002/ardp.201200392
By:
- Fernández ‐ Fernández, Cristina;
- Decara, Juan;
- Bermúdez ‐ Silva, Francisco J.;
- Sánchez, Eva;
- Morales, Paula;
- Gómez ‐ Cañas, María;
- Gómez ‐ Ruíz, María;
- Callado, Luis F.;
- Goya, Pilar;
- Rodríguez de Fonseca, Fernando;
- Martín, M. Isabel;
- Fernández ‐ Ruíz, Javier;
- Meana, J. Javier;
- Jagerovic, Nadine
Publication type:
Article
The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways.
Published in:
Scientific Reports, 2016, p. 21703, doi. 10.1038/srep21703
By:
- del Río, Carmen;
- Navarrete, Carmen;
- Collado, Juan A.;
- Bellido, M. Luz;
- Gómez-Cañas, María;
- Pazos, M. Ruth;
- Fernández-Ruiz, Javier;
- Pollastro, Federica;
- Appendino, Giovanni;
- Calzado, Marco A.;
- Cantarero, Irene;
- Muñoz, Eduardo
Publication type:
Article
Structure–Effect Relationships of Novel Semi-Synthetic Cannabinoid Derivatives.
Published in:
Frontiers in Pharmacology, 2019, v. 10, p. 1, doi. 10.3389/fphar.2019.01284
By:
- Götz, Marcus R.;
- Collado, Juan A.;
- Fernández-Ruiz, Javier;
- Fiebich, Bernd L.;
- García-Toscano, Laura;
- Gómez-Cañas, María;
- Koch, Oskar;
- Leha, Andreas;
- Muñoz, Eduardo;
- Navarrete, Carmen;
- Pazos, Maria R.;
- Holzgrabe, Ulrike
Publication type:
Article
Chromenopyrazoles: Non-psychoactive and Selective CB1 Cannabinoid Agonists with Peripheral Antinociceptive Properties.
Published in:
ChemMedChem, 2012, v. 7, n. 3, p. 452, doi. 10.1002/cmdc.201100568
By:
- Cumella, Jose;
- Hernández-Folgado, Laura;
- Girón, Rocio;
- Sánchez, Eva;
- Morales, Paula;
- Hurst, Dow P.;
- Gómez-Cañas, Maria;
- Gómez-Ruiz, Maria;
- Pinto, Diana C. G. A.;
- Goya, Pilar;
- Reggio, Patricia H.;
- Martin, María Isabel;
- Fernández-Ruiz, Javier;
- Silva, Artur M. S.;
- Jagerovic, Nadine
Publication type:
Article
Inside Back Cover: Chromenopyrazoles: Non-psychoactive and Selective CB1 Cannabinoid Agonists with Peripheral Antinociceptive Properties (ChemMedChem 3/2012).
Published in:
ChemMedChem, 2012, v. 7, n. 3, p. 536, doi. 10.1002/cmdc.201290011
By:
- Cumella, Jose;
- Hernández-Folgado, Laura;
- Girón, Rocio;
- Sánchez, Eva;
- Morales, Paula;
- Hurst, Dow P.;
- Gómez-Cañas, Maria;
- Gómez-Ruiz, Maria;
- Pinto, Diana C. G. A.;
- Goya, Pilar;
- Reggio, Patricia H.;
- Martin, María Isabel;
- Fernández-Ruiz, Javier;
- Silva, Artur M. S.;
- Jagerovic, Nadine
Publication type:
Article
A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis.
Published in:
Journal of NeuroImmune Pharmacology, 2012, v. 7, n. 4, p. 1002, doi. 10.1007/s11481-012-9399-3
By:
- Granja, Aitor;
- Carrillo-Salinas, Francisco;
- Pagani, Alberto;
- Gómez-Cañas, María;
- Negri, Roberto;
- Navarrete, Carmen;
- Mecha, Miriam;
- Mestre, Leyre;
- Fiebich, Bend;
- Cantarero, Irene;
- Calzado, Marco;
- Bellido, Maria;
- Fernandez-Ruiz, Javier;
- Appendino, Giovanni;
- Guaza, Carmen;
- Muñoz, Eduardo
Publication type:
Article
Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson's Disease and Amyotrophic Lateral Sclerosis.
Published in:
Molecules, 2021, v. 26, n. 24, p. 7643, doi. 10.3390/molecules26247643
By:
- Burgaz, Sonia;
- García, Concepción;
- Gonzalo-Consuegra, Claudia;
- Gómez-Almería, Marta;
- Ruiz-Pino, Francisco;
- Unciti, Juan Diego;
- Gómez-Cañas, María;
- Alcalde, Juan;
- Morales, Paula;
- Jagerovic, Nadine;
- Rodríguez-Cueto, Carmen;
- de Lago, Eva;
- Muñoz, Eduardo;
- Fernández-Ruiz, Javier
Publication type:
Article
Neuroprotection with the Cannabidiol Quinone Derivative VCE-004.8 (EHP-101) against 6-Hydroxydopamine in Cell and Murine Models of Parkinson's Disease.
Published in:
Molecules, 2021, v. 26, n. 11, p. 3245, doi. 10.3390/molecules26113245
By:
- Burgaz, Sonia;
- García, Concepción;
- Gómez-Cañas, María;
- Rolland, Alain;
- Muñoz, Eduardo;
- Fernández-Ruiz, Javier
Publication type:
Article
Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson's Disease.
Published in:
Molecules, 2019, v. 24, n. 15, p. 2702, doi. 10.3390/molecules24152702
By:
- Burgaz, Sonia;
- García, Concepción;
- Gómez-Cañas, Maria;
- Muñoz, Eduardo;
- Fernández-Ruiz, Javier;
- Capasso, Raffaele;
- Iannotti, Fabio Arturo
Publication type:
Article
Editorial: Cannabinoids as potential treatment for neurological diseases.
Published in:
Frontiers in Neuroscience, 2022, v. 16, p. 1, doi. 10.3389/fnins.2022.1108101
By:
- Gómez-Cañas, María;
- Morales, Paula;
- Satta, Valentina;
- Rodríguez-Cueto, Carmen;
- García, Concepción;
- Sagredo, Onintza
Publication type:
Article

Works by Gómez-Cañas, Maria

Δ<sup>9</sup> -Tetrahydrocannabinolic acid alleviates collagen-induced arthritis: Role of PPARγ and CB<sub>1</sub> receptors.

VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARγ- and CB<sub>2</sub> receptor-dependent pathways.

Prospects for cannabinoid therapies in basal ganglia disorders.

Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor.

Description of a Bivalent Cannabinoid Ligand with Hypophagic Properties.

The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways.

Structure–Effect Relationships of Novel Semi-Synthetic Cannabinoid Derivatives.

Chromenopyrazoles: Non-psychoactive and Selective CB<sub>1</sub> Cannabinoid Agonists with Peripheral Antinociceptive Properties.

Inside Back Cover: Chromenopyrazoles: Non-psychoactive and Selective CB<sub>1</sub> Cannabinoid Agonists with Peripheral Antinociceptive Properties (ChemMedChem 3/2012).

A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis.

Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson's Disease and Amyotrophic Lateral Sclerosis.

Neuroprotection with the Cannabidiol Quinone Derivative VCE-004.8 (EHP-101) against 6-Hydroxydopamine in Cell and Murine Models of Parkinson's Disease.

Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson's Disease.

Editorial: Cannabinoids as potential treatment for neurological diseases.